| Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC (NCT06598761) | Peking University First Hospital | 2022-01-01 |
| Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs (NCT06652022) | Peking University First Hospital | 2022-01-01 |
| UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. (NCT05043662) | Changhai Hospital | 2021-09-01 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA (NCT04197414) | Yonsei University | 2019-12-06 |
| Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases (NCT03520231) | University Health Network, Toronto | 2018-09-04 |
| Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma (NCT03291028) | Fox Chase Cancer Center | 2017-11-27 |
| Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172) | University of Chicago | 2017-09-13 |
| Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy (NCT03193788) | Asan Medical Center | 2017-01-01 |
| Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma (NCT03296306) | Asan Medical Center | 2016-09-01 |
| CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma (NCT03013920) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-08-01 |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer (NCT02300610) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-11 |
| A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function (NCT02665039) | Dr Anders Ullén | 2014-04-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521) | University of Southern California | 2013-05-01 |
| Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract (NCT01844947) | Dr Anders Ullén | 2012-05-01 |
| TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma (NCT01328574) | National Cancer Institute (NCI) | 2011-03-01 |
| Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies (NCT01182168) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer (NCT01191892) | Cardiff University | 2010-06-01 |
| A Genotype-Phenotype Urothelial Cancer Registry (NCT00902590) | Memorial Sloan Kettering Cancer Center | 2009-05-01 |
| A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer (NCT00661609) | AstraZeneca | 2008-05-01 |
| Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum (NCT01426126) | Asan Medical Center | 2007-12-01 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
| Arsenic Trioxide in Treating Patients With Urothelial Cancer (NCT00009867) | National Cancer Institute (NCI) | 2000-12-01 |